0.6500
-0.0100
(-1.52%)
At close: January 31 at 7:59:54 PM GMT+1
Breakdown
12/31/2023
12/31/2022
12/31/2021
Total Assets
119.0000
47.0000
172.0000
Total Liabilities Net Minority Interest
875.0000
795.0000
283.0000
Total Equity Gross Minority Interest
-756.0000
-748.0000
-111.0000
Total Capitalization
-756.0000
-748.0000
-111.0000
Common Stock Equity
-756.0000
-748.0000
-111.0000
Net Tangible Assets
-756.0000
-748.0000
-111.0000
Working Capital
-759.0000
-753.0000
-123.0000
Invested Capital
-614.0000
-333.0000
-111.0000
Tangible Book Value
-756.0000
-748.0000
-111.0000
Total Debt
142.0000
415.0000
--
Net Debt
82.0000
381.0000
--
Share Issued
53,815.1420
53,815.1420
53,815.1420
Ordinary Shares Number
53,815.1420
53,815.1420
53,815.1420
12/31/2021 - 8/11/2023
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
VX1.HM Vertex Pharmaceuticals Inc
447.95
+6.10%
22UA.F BioNTech SE
119.90
+0.84%
22UA.DE BioNTech SE
118.40
-0.17%
RNXT RenovoRx, Inc.
1.3600
+2.26%
DTIL Precision BioSciences, Inc.
5.01
-3.84%
AMLX Amylyx Pharmaceuticals, Inc.
3.6500
+3.99%
CGTX Cognition Therapeutics, Inc.
0.7230
-5.90%
CVAC CureVac N.V.
3.7900
-0.79%
REVB Revelation Biosciences, Inc.
3.7700
-1.31%
EYEN Eyenovia, Inc.
0.0346
-0.86%